Interleukin-1β and adverse effects on cerebral blood flow during long-term global hypoperfusion

Journal of Neurosurgery

Volumn 99, Issue 5, 2003, Pages 907-912

  Maher, Cormac O ^a   Anderson, Robert E ^a   Martin, Heidi S ^a   McClelland, Robyn L ^a   Meyer, Fredric B ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cerebral blood flow; Cytokine; Interleukin 1 ; Rat

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; SODIUM CHLORIDE; XENON 133; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; SIALOGLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR DISEASE; CLEARANCE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; EVALUATION; EXPERIMENTAL MODEL; LONG TERM CARE; MALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; VERTEBRAL ARTERY STENOSIS; ANIMAL; DISEASE MODEL; DRUG ANTAGONISM; FOLLOW UP; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; DISEASE MODELS, ANIMAL; FOLLOW-UP STUDIES; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS; TIME FACTORS;

EID: 0142213823     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.99.5.0907     Document Type: Article

References (67)

1. Aihara Y, Kasuya H, Onda H, et al: Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke 32:212-217, 2001
2. Andersen AM, Ladefoged J: Partition coefficient of 133Xe between tissues and blood in vivo. Scand J Clin Lab Invest 199:72-78, 1967
3. Bonmann E, Suschek C, Spranger M, et al: The dominant role of exogenous or endogenous interleukin-1 beta on expression and activity of inducible nitric oxide synthase in rat microvascular brain endothelial cells. Neurosci Lett 230:109-112, 1997
4. Boutin H, LeFeuvre RA, Horai R, et al: Role of IL-1α and IL-1β in ischemic brain damage. J Neurosci 21:5528-5534, 2001
5. Brian JE Jr, Faraci FM: Tumor necrosis factor-alpha-induced dilation of cerebral arterioles. Stroke 29:509-515, 1998
6. Childers MK, Rupright J, Smith DW: Post-traumatic hyperthermia in acute brain injury rehabilitation. Brain Inj 8:335-343, 1994
7. Chyatte D, Rusch N, Sundt TM Jr: Prevention of chronic experimental cerebral vasospasm with ibuprofen and high-dose methylprednisolone. J Neurosurg 59:925-932, 1983
8. de la Torre JC, Fortin T: Partial or global rat brain ischemia: the SCOT model. Brain Res Bull 26:365-372, 1991
9. De Simoni MG, De Luigi A, Gemma L, et al: Modulation of systemic interleukin-6 induction by central interleukin-1. Am J Physiol 265:R739-R742, 1993
10. De Simoni MG, Sironi M, De Luigi A, et al: Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin-6. J Exp Med 171:1773-1778, 1990
11. Dietrich HH, Dacey RG: Molecular keys to the problem of cerebral vasospasm. Neurosurgery 46:517-530, 2000
12. Fassbender K, Hodapp B, Rossol S, et al: Inflammatory cytokines in subarachnoid hemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry 70:534-537, 2001
13. Fisher M, Plante GM, Doyle EM: Inhibition of inflammatory cell-mediated myelin oxidation and interleukin-1 beta generation by a 21-aminosteroid, U74500A. J Neurol Sci 119:189-194, 1993
14. Gaetani P, Tartara F, Pignatti P, et al: Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 20:337-342, 1998
15. Garcia JH, Liu KF, Relton JK: Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol 147:1477-1486, 1995
16. 133xenon cerebral blood flow measurements before, during, and following focal incomplete ischemia in the squirrel monkey. Circ Res 36:18-26, 1975
17. Helle M, Brackenhoff JPJ, DeGroot ER, et al: Interleukin-6 is involved in Interleukin-1-induced activity. Eur J Immunol 18:957-959, 1988
18. Hillhouse EW, Kida S, Iannotti F: Middle cerebral artery occlusion in the rat causes biphasic production of immunoreactive interleukin-1beta in the cerebral cortex. Neurosci Lett 249:177-179, 1998
19. Holmin S, Mathiesen T: Intracerebral administration of interleukin-1β and induction of inflammation, apoptosis, and vasogenic edema. J Neurosurg 92:108-120, 2000
20. Hopkins SJ, Rothwell NJ: Cytokines and the nervous system: I. Expression and Recognition. Trends Neurosci 18:83-88, 1995
21. Ito A, Shimokawa H, Fukumoto Y, et al: The role of fibroblast growth factor-2 in the vascular effects of interleukin-1 in porcine coronary arteries in vivo. Cardiovasc Res 32:570-579, 1996
22. Kanno K, Hirata Y, Imai T, et al: Regulation of inducible nitric oxide synthase gene by interleukin-1β in rat vascular endothelial cells. Am J Physiol Heart Circ Physiol 267:H2318-H2324, 1994
23. Kassell NF, Haley EC Jr, Apperson-Hansen C, et al: Randomized, double-blind, vehicle-controlled trial of tirilizad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84:221-228, 1996
24. Kikuchi T, Okuda Y, Kaito N, et al: Cytokine production in cerebrospinal fluid after subarachnoid hemorrhage. Neurol Res 17:106-108, 1995
25. Klir JJ, McClellan JL, Kluger MJ: Interleukin-1β causes the increase in anterior hypothalamic interleukin-6 during LPS-induced fever in rats. Am J Physiol 266:R1845-R1848, 1994
26. Konsman JP, Tridon V, Dantzer R: Diffusion and action of intracerebroventriculary injected interleukin-1 in the CNS. Neuroscience 101:957-967, 2000
27. Legos JJ, Whitmore RG, Erhardt JA, et al: Quantitative changes in interleukin proteins following focal stroke in the rat. Neurosci Lett 282:189-192, 2000
28. LeMay LG, Otterness IG, Vander A, et al: In vivo evidence that the rise in plasma IL-6 following injection of a fever-inducing dose of LPS is mediated by IL-1β. Cytokine 2:199-204, 1990
29. Lin MT, Kao TY, Jin YT, et al: Interleukin-1 receptor antagonist attenuates the heat stroke-induced neuronal damage by reducing the cerebral ischemia in rats. Brain Res Bull 37:595-598, 1995
30. Loddick SA, Rothwell NJ: Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 16:932-940, 1996
31. Long NC, Otterness IG, Kunkel SL, et al: Role of interleukin-1β and tumor necrosis factor in lipopolysaccharide fever in rats. Am J Physiol 259 (Regulatory Integrative Comp Physiol 28): R724-R728, 1990
32. Lopez-Cortes LF, Marquez-Arbizu R, Jimenez-Jimenez LM, et al: Cerebrospinal fluid tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, and interleukin-8 as diagnostic markers of cerebrospinal fluid infection in neurosurgical patients. Crit Care Med 28:215-219, 2000
33. Maiuri F, Gallicchio B, Donati P, et al: The blood leucocyte count and its prognostic significance in subarachnoid hemorrhage. J Neurosurg Sci 31:45-48, 1988
34. Mathiesen T, Edner G, Ulfarsson E, et al: Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-α following subarachnoid hemorrhage. J Neurosurg 87:215-220, 1997
35. Monroy M, Kuluz JW, He D, et al: Role of nitric oxide in the cerebrovascular and thermoregulatory response to interleukin-1β. Am J Physiol Heart Circ Physiol 280:H1448-H1453, 2001
36. Nam DH, Kim JS, Hong SC, et al: Expression of interleukin-1β in lipopolysaccharide stimulated monocytes derived from patients with aneurysmal subarachnoid hemorrhage is correlated with cerebral vasospasm. Neurosci Lett 312:41-44, 2001
37. Neil-Dwyer G, Cruickshank J: The blood leucocyte count and its prognostic significance in subarachnoid hemorrhage. Brain 97:79-86, 1974
38. Onda H, Kasuya H, Takakura K, et al: Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab 19:1279-1288, 1999
39. Osuka K, Suzuki Y, Tanazawa T, et al: Interleukin-6 and development of vasospasm after subarachnoid hemorrhage. Acta Neurochir 140:943-951, 1998
40. Osuka K, Suzuki Y, Watanabe Y, et al: Vasodilator effects on canine basilar artery induced by intracisternal interleukin-1β. J Cereb Blood Flow Metab 17:1337-1345, 1997
41. Pellettieri L, Nilsson B, Carlsson CA, et al: Serum immunocomplexes in patients with subarachnoid hemorrhage. Neurosurgery 19:767-771, 1986
42. Peterson JW, Kwun BD, Hackett JD, et al: The role of inflammation in experimental cerebral vasospasm. J Neurosurg 72:767-774, 1990
43. Peterson JW, Kwun BD, Teramura A, et al: Immunological reaction against the aging human subarachnoid erythrocyte: a model for the onset of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 71:718-726, 1989
44. Plata-Salaman CR, Kelly G, Agresta C, et al: Interleukin-1 beta enhances spinal cord blood flow after intrathecal administration in the normal rat. Am J Physiol 269:R1032-R1037, 1995
45. Pulsinelli WA, Buchan AM: The four-vessel occlusion rat model: method for complete occlusion of vertebral arteries and control of collateral circulation. Stroke 19:913-914, 1988
46. Relton JK, Rothwell NJ: Interleukin-1 receptor antagonist inhibits ischemic and excitotoxic neuronal damage in the rat. Brain Res Bull 29:243-246, 1992
47. Romero LI, Kakucska I, Lechan RM, et al: Interleukin-6 (IL-6) is secreted from the brain after intracerebroventricular injection of IL-1β in rats. Am J Physiol 270:R518-R524, 1996
48. Rothwell NJ: Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol Sci 12:430-436, 1991
49. Rothwell NJ, Hopkins SJ: Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci 18:130-136, 1995
50. Shibata M, Lefler CW, Busija DW: Recombinant human interleukin-1α dilates pial arterioles and increases cerebrospinal fluid prostanoids in piglets. Am J Physiol Heart Circ Physiol 259: H1486-H1499, 1990
51. Shibata M, Parfenova H, Zuckerman SL, et al: Interleukin-1β peptides induce cerebral pial arteriolar dilation in anesthetized newborn pigs. Am J Physiol 270:R1044-R1050, 1996
52. Shibata M, Parfenova H, Zuckerman SL, et al: Tumor necrosis factor-alpha induces pial arteriolar dilation in newborn pigs. Brain Res Bull 39:241-247, 1996
53. Shimokawa H, Ito A, Fukumoto Y, et al: Chronic treatment with interleukin-1β induces coronary intimal lesions and vasospastic responses in pigs in vivo: the role of platelet-derived growth factor. J Clin Invest 97:769-776, 1996
54. Stahel PF, Shohami E, Younis FM, et al: Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J Cereb Blood Flow Metab 20:369-380, 2000
55. Stroemer RP, Rothwell NJ: Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat. J Cereb Blood Flow Metab 17:597-604, 1997
56. Tarkowski E, Rosengren L, Blomstrand C, et al: Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26:1393-1398, 1995
57. Touzani O, Boutin H, Chuquet J, et al: Potential mechanisms of interleukin-1 involvement in cerebral ischemia. J Neuroimmunol 100:203-215, 1999
58. Wang X, Barone FC, Aiyar NV, et al: Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke 28:155-161, 1997
59. Wang X, Yue TL, Barone FC, et al: Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol 23:103-114, 1994
60. Weir B, Disney L, Grace M, et al: Daily trends in white blood cell count and temperature after subarachnoid hemorrhage from aneurysm. Neurosurgery 25:161-165, 1989
61. Weir B, Macdonald RL, Stoodley M: Etiology of cerebral vasospasm. Acta Neurochir Suppl 72:27-46, 1999
62. Weiss JM, Quan N, Sundar SK: Widespread activation and consequences of interleukin-1 in the brain. Ann NY Acad Sci 741:338-357, 1994
63. Woiciechowsky C, Schoning B, Daberkow N, et al: Brain IL-1β induces local inflammation but systemic anti-inflammatory response through stimulation of both hypothalamic-pituitary-adrenal axis and sympathetic nervous system. Brain Res 816:563-571, 1999
64. Xiao E, Xia L, Ferin M, et al: Intracerebroventricular injection of interleukin-1 stimulates the release of high levels of interleukin-6 and interleukin-1 receptor antagonist into peripheral blood in the primate. J Neuroimmunol 97:70-76, 1999
65. Yamasaki Y, Matsuura N, Shozuhara H, et al: Interleukin-1 as a photogenic mediator of ischemic brain damage in rats. Stroke 26:676-681, 1995
66. Yang GY, Liu XH, Kadoya C, et al: Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist. J Cereb Blood Flow Metab 18:840-847, 1998
67. Zhang Z, Chopp M, Goussev A, et al: Cerebral vessels express interleukin 1beta after focal cerebral ischemia. Brain Res 784:210-217, 1998